Related Experiment Video

Updated: Jun 2, 2026

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

Published on: April 28, 2020

Differential response related to genotoxicity in multiple organs of cirrhotic rats

Marcia R Nagaoka1, Luciana Le Sueur-Maluf, Odair Aguiar

  • 1Departamento de Biociências, Universidade Federal de Sao Paulo, UNIFESP, Santos, SP, Brazil.

Hepatology International
|April 13, 2011
PubMed
Abstract

Insights

Cirrhosis induces DNA damage in liver and brain cells of rats, as shown by the comet assay. Blood, heart, and kidney cells were not affected, indicating specific organ sensitivity to cirrhosis-induced genetic instability.

Area of Science:

  • Biochemistry
  • Genetics
  • Toxicology

Background:

  • Cirrhosis, a chronic liver disease, can lead to systemic complications.
  • Assessing organ-specific DNA damage is crucial for understanding cirrhosis-induced genetic instability.

Purpose of the Study:

  • To evaluate DNA damage in blood, liver, heart, kidney, and brain of cirrhotic rats using the single cell gel (comet) assay.
  • To determine if specific organs are more susceptible to genetic instability caused by cirrhosis.

Main Methods:

  • Wistar rats underwent bile duct ligation for 28 days to induce cirrhosis.
  • The single cell gel (comet) assay was performed on blood, liver, heart, kidney, and brain tissues.
  • DNA damage was quantified by measuring the mean tail moment.

Main Results:

  • Cirrhosis induced significant genetic damage in liver and brain cells.
  • No significant DNA damage was observed in blood, heart, or kidney cells compared to controls.
  • The comet assay effectively detected organ-specific DNA damage.

Conclusions:

  • Cirrhosis contributes to DNA damage in liver and brain tissues.
  • Liver and brain are sensitive organs to cirrhosis-induced genetic damage.
  • The findings highlight potential mechanisms of cirrhosis-related genetic instability.

More Related Videos

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat09:27

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat

Published on: June 17, 2016

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...